Financial Snapshot

Revenue
$6.515M
TTM
Gross Margin
-52.18%
TTM
Net Earnings
-$82.26M
TTM
Current Assets
$5.071M
Q3 2023
Current Liabilities
$667.0K
Q3 2023
Current Ratio
760.35%
Q3 2023
Total Assets
$402.6M
Q3 2023
Total Liabilities
$667.0K
Q3 2023
Book Value
$401.9M
Q3 2023
Cash
P/E
-4.725
Nov 29, 2024 EST
Free Cash Flow

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 1998 1997 1996 1995 1994 1993 1992
Revenue $3.499M $3.020M $2.286M $3.390M $2.440M $1.990M $1.680M $1.440M $1.320M $880.0K $520.0K $2.140M $570.0K $1.820M $460.0K $1.670M $2.880M $2.300M $890.0K $320.0K $610.0K $930.0K $1.770M $140.0K $320.0K $420.0K $200.0K $440.0K $350.0K $360.0K
YoY Change 15.85% 32.09% -32.56% 38.93% 22.61% 18.45% 16.67% 9.09% 50.0% 69.23% -75.7% 275.44% -68.68% 295.65% -72.46% -42.01% 25.22% 158.43% 178.13% -47.54% -34.41% -47.46% -56.25% -23.81% 110.0% -54.55% 25.71% -2.78%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 1998 1997 1996 1995 1994 1993 1992
Revenue $3.499M $3.020M $2.286M $3.390M $2.440M $1.990M $1.680M $1.440M $1.320M $880.0K $520.0K $2.140M $570.0K $1.820M $460.0K $1.670M $2.880M $2.300M $890.0K $320.0K $610.0K $930.0K $1.770M $140.0K $320.0K $420.0K $200.0K $440.0K $350.0K $360.0K
Cost Of Revenue $4.750M $5.020M $5.603M $4.780M $4.480M $4.770M $4.610M $4.550M $5.650M $4.140M $3.100M $2.480M $3.020M $2.990M $2.850M $3.760M $3.620M $2.930M $2.810M $2.780M $2.440M $2.860M $3.260M $1.640M $1.630M $1.600M $1.130M $870.0K $680.0K $220.0K
Gross Profit -$1.251M -$2.000M -$3.316M -$1.390M -$2.040M -$2.790M -$2.930M -$3.110M -$4.330M -$3.260M -$2.580M -$330.0K -$2.450M -$1.160M -$2.390M -$2.100M -$750.0K -$630.0K -$1.920M -$2.450M -$1.830M -$1.930M -$1.490M -$1.500M -$1.310M -$1.180M -$930.0K -$430.0K -$330.0K $140.0K
Gross Profit Margin -35.76% -66.23% -145.05% -41.0% -83.61% -140.2% -174.4% -215.97% -328.03% -370.45% -496.15% -15.42% -429.82% -63.74% -519.57% -125.75% -26.04% -27.39% -215.73% -765.63% -300.0% -207.53% -84.18% -1071.43% -409.37% -280.95% -465.0% -97.73% -94.29% 38.89%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 1998 1997 1996 1995 1994 1993 1992
Selling, General & Admin $781.9K $840.0K $674.7K $590.0K $700.0K $690.0K $830.0K $550.0K $250.0K $370.0K $440.0K $750.0K $1.150M $630.0K $590.0K $680.0K $720.0K $550.0K $510.0K $530.0K $450.0K $470.0K $340.0K $230.0K $190.0K $250.0K
YoY Change -6.92% 24.51% 14.35% -15.71% 1.45% -16.87% 50.91% 120.0% -32.43% -15.91% -41.33% -34.78% 82.54% 6.78% -13.24% -5.56% 30.91% 7.84% -3.77% 17.78% -4.26% 38.24% 21.05%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $10.00K $10.00K $10.00K $10.00K $10.00K $0.00
YoY Change 0.0% 0.0% 0.0% 0.0%
% of Gross Profit 0.0%
Operating Expenses $924.3K $990.0K $822.8K $730.0K $840.0K $820.0K $950.0K $680.0K $390.0K $500.0K $590.0K $950.0K $1.350M $790.0K $760.0K $820.0K $970.0K $710.0K $660.0K $610.0K $510.0K $590.0K $450.0K $240.0K $230.0K $290.0K $300.0K $430.0K $430.0K $190.0K
YoY Change -6.64% 20.33% 12.71% -13.1% 2.44% -13.68% 39.71% 74.36% -22.0% -15.25% -37.89% -29.63% 70.89% 3.95% -7.32% -15.46% 36.62% 7.58% 8.2% 19.61% -13.56% 31.11% 4.35% -20.69% -3.33% -30.23% 0.0% 126.32%
Operating Profit -$2.175M -$2.990M -$4.139M -$2.120M -$2.880M -$3.610M -$3.880M -$3.790M -$4.720M -$3.760M -$3.170M -$1.280M -$3.800M -$1.950M -$3.150M -$2.920M -$1.720M -$1.340M -$2.580M -$3.060M -$2.340M -$2.520M -$1.940M -$1.740M -$1.540M -$1.470M -$1.230M -$860.0K -$760.0K -$50.00K
YoY Change -27.24% -27.76% 95.24% -26.39% -20.22% -6.96% 2.37% -19.7% 25.53% 18.61% 147.66% -66.32% 94.87% -38.1% 7.88% 69.77% 28.36% -48.06% -15.69% 30.77% -7.14% 29.9% 12.99% 4.76% 19.51% 43.02% 13.16% 1420.0%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 1998 1997 1996 1995 1994 1993 1992
Interest Expense $24.53M -$101.6M $68.67M $125.2M -$67.60M $32.27M $72.43M -$8.120M $45.22M $93.03M $87.82M $78.91M
YoY Change -124.14% -247.97% -45.14% -285.16% -309.48% -55.45% -992.0% -117.96% -51.39% 5.93% 11.29%
% of Operating Profit
Other Income/Expense, Net
YoY Change

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 1998 1997 1996 1995 1994 1993 1992
Pretax Income $22.35M -$104.6M $64.53M $123.1M -$70.48M $28.66M $68.56M -$11.91M $40.50M $89.27M $84.65M $77.63M $37.47M $10.19M -$21.67M $60.25M $50.51M -$21.44M $44.76M $7.160M $38.62M -$50.41M -$95.03M -$30.38M $15.19M $21.81M $27.86M -$8.590M -$790.0K -$2.030M
YoY Change -121.37% -262.09% -47.56% -274.59% -345.92% -58.2% -675.65% -129.41% -54.63% 5.46% 9.04% 107.18% 267.71% -147.02% -135.97% 19.28% -335.59% -147.9% 525.14% -81.46% -176.61% -46.95% -300.0% -30.35% -21.72% -424.33% 987.34% -61.08%
Income Tax $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
% Of Pretax Income 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Net Earnings $22.35M -$104.6M $64.53M $123.1M -$70.48M $28.66M $68.56M -$11.91M $40.50M $89.27M $84.65M $77.63M $37.47M $10.19M -$21.67M $60.25M $50.51M -$21.44M $44.76M $7.160M $38.62M -$50.41M -$95.03M -$30.38M $15.19M $21.81M $27.86M -$8.590M -$790.0K -$2.030M
YoY Change -121.37% -262.09% -47.56% -274.59% -345.92% -58.2% -675.65% -129.41% -54.63% 5.46% 9.04% 107.18% 267.71% -147.02% -135.97% 19.28% -335.59% -147.9% 525.14% -81.46% -176.61% -46.95% -300.0% -30.35% -21.72% -424.33% 987.34% -61.08%
Net Earnings / Revenue 638.85% -3463.58% 2822.51% 3629.79% -2888.52% 1440.2% 4080.95% -827.08% 3068.18% 10144.32% 16278.85% 3627.57% 6573.68% 559.89% -4710.87% 3607.78% 1753.82% -932.17% 5029.21% 2237.5% 6331.15% -5420.43% -5368.93% -21700.0% 4746.88% 5192.86% 13930.0% -1952.27% -225.71% -563.89%
Basic Earnings Per Share
Diluted Earnings Per Share $0.83 -$4.07 $2.616M $5.153M -$3.041M $1.279M $3.178M -$574.3K $2.057M $4.696M $5.647M $5.380M $2.570M $466.6K -$987.2K $2.858M $2.515M -$1.115M $3.550M $593.2K $3.385M -$4.842M -$10.20M -$4.167M $2.167M $3.265M $4.171M -$1.286M -$204.7K -$525.9K

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 1998 1997 1996 1995 1994 1993 1992
Cash & Short-Term Investments $480.00 $0.00 $990.00 $1.100M $0.00 $600.0K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $5.500M $0.00 $0.00 $0.00 $0.00 $700.0K $1.100M $100.0K $400.0K $100.0K $200.0K $1.200M $100.0K $200.0K $900.0K
YoY Change -100.0% -100.0% -100.0% -100.0% -36.36% 1000.0% -75.0% -50.0% -83.33% 1100.0% -50.0% -77.78%
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets $26.09K $0.00 $26.30K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $100.0K $100.0K $100.0K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% 0.0% 0.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $5.071M $600.0K $171.0K $100.0K $5.100M $11.20M $600.0K $9.900M $1.300M $100.0K $100.0K $200.0K $800.0K $500.0K $8.600M $1.900M $300.0K $1.400M $2.500M $1.200M $1.200M $1.100M $1.900M $100.0K $100.0K $200.0K $1.200M $100.0K $200.0K $900.0K
YoY Change 745.2% 250.96% 70.96% -98.04% -54.46% 1766.67% -93.94% 661.54% 1200.0% 0.0% -50.0% -75.0% 60.0% -94.19% 352.63% 533.33% -78.57% -44.0% 108.33% 0.0% 9.09% -42.11% 0.0% -50.0% -83.33% 1100.0% -50.0% -77.78%
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $397.5M $414.1M $534.0M $484.0M $381.5M $466.5M $467.0M $407.4M $466.3M $444.2M $302.3M $226.0M $170.0M $255.4M $255.9M $277.9M $308.8M $269.4M $227.7M $191.8M $191.7M $156.8M $214.0M $101.3M $132.1M $123.5M $100.6M $73.40M $50.40M $52.40M
YoY Change -4.0% -22.45% 10.33% 26.87% -18.22% -0.11% 14.63% -12.63% 4.98% 46.94% 33.76% 32.94% -33.44% -0.2% -7.92% -10.01% 14.63% 18.31% 18.72% 0.05% 22.26% -26.73% -23.32% 6.96% 22.76% 37.06% 45.63% -3.82%
Other Assets
YoY Change
Total Long-Term Assets $397.5M $414.1M $534.0M $484.1M $381.9M $467.3M $467.7M $407.7M $466.6M $444.7M $302.7M $227.3M $170.8M $256.3M $256.5M $279.1M $308.8M $269.4M $227.8M $191.9M $191.8M $156.8M $214.0M $101.3M $132.1M $123.5M $100.5M $73.50M $50.40M $52.50M
YoY Change -4.0% -22.46% 10.31% 26.76% -18.28% -0.09% 14.72% -12.62% 4.92% 46.91% 33.17% 33.08% -33.36% -0.08% -8.1% -9.62% 14.63% 18.26% 18.71% 0.05% 22.32% -26.73% -23.32% 6.96% 22.89% 36.73% 45.83% -4.0%
Total Assets $402.6M $414.7M $534.2M $484.2M $387.0M $478.5M $468.3M $417.6M $467.9M $444.8M $302.8M $227.5M $171.6M $256.8M $265.1M $281.0M $309.1M $270.8M $230.3M $193.1M $193.0M $157.9M $215.9M $101.4M $132.2M $123.7M $101.7M $73.60M $50.60M $53.40M
YoY Change
Accounts Payable $11.10M $8.700M $2.800M $2.300M $1.300M $2.100M $4.200M $100.0K $0.00 $600.0K $4.800M $16.00M $2.700M $600.0K $2.100M $600.0K $900.0K $2.300M $300.0K $1.200M $400.0K $200.0K $0.00 $0.00 $1.900M
YoY Change 27.59% 21.74% 76.92% -38.1% -50.0% 4100.0% -87.5% -70.0% 492.59% 350.0% -71.43% 250.0% -33.33% -60.87% 100.0% -100.0%
Accrued Expenses $667.0K $600.0K $703.1K $600.0K $500.0K $600.0K $700.0K $600.0K $800.0K $600.0K $500.0K $400.0K $400.0K $500.0K $500.0K $500.0K $500.0K $600.0K $400.0K $400.0K $400.0K $300.0K $400.0K $200.0K $200.0K $200.0K $200.0K $200.0K $100.0K $200.0K
YoY Change 11.16% -14.67% 17.19% 20.0% -16.67% -14.29% 16.67% -25.0% 33.33% 20.0% 25.0% 0.0% -20.0% 0.0% 0.0% 0.0% -16.67% 50.0% 0.0% 0.0% 33.33% -25.0% 0.0% 0.0% 0.0% 0.0% 100.0% -50.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $667.0K $16.80M $9.403M $600.0K $3.300M $2.900M $2.000M $2.700M $5.000M $700.0K $500.0K $400.0K $1.000M $5.300M $16.50M $3.200M $1.100M $2.700M $1.000M $1.300M $2.700M $300.0K $700.0K $1.400M $200.0K $600.0K $400.0K $200.0K $100.0K $2.100M
YoY Change -96.03% 78.66% 1467.19% -81.82% 13.79% 45.0% -25.93% -46.0% 614.29% 40.0% 25.0% -60.0% -81.13% -67.88% 415.63% 190.91% -59.26% 170.0% -23.08% -51.85% 800.0% -57.14% 600.0% -66.67% 50.0% 100.0% 100.0% -95.24%
Long-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.342M $0.00 $0.00 $0.00 $0.00
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $1.342M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change -100.0%
Total Liabilities $667.0K $16.80M $10.75M $600.0K $3.300M $3.000M $2.000M $2.700M $5.000M $800.0K $500.0K $400.0K $1.000M $5.400M $16.50M $3.200M $1.100M $2.700M $1.000M $1.300M $2.600M $300.0K $800.0K $1.400M $200.0K $600.0K $400.0K $200.0K $100.0K $2.100M
YoY Change -96.03% 56.35% 1690.85% -81.82% 10.0% 50.0% -25.93% -46.0% 525.0% 60.0% 25.0% -60.0% -81.48% -67.27% 415.63% 190.91% -59.26% 170.0% -23.08% -50.0% 766.67% -62.5% 600.0% -66.67% 50.0% 100.0% 100.0% -95.24%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 1998 1997 1996 1995 1994 1993 1992
Basic Shares Outstanding
Diluted Shares Outstanding
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $388.65 Million

About abrdn Life Sciences Investors

abrdn Life Sciences Investors is a US-based company operating in industry. The company is headquartered in Philadelphia, Pennsylvania. abrdn Life Sciences Investors (the Fund), formerly Tekla Life Sciences Investors, is a non-diversified closed-end management investment company. The Fund's investment objective is long-term capital appreciation through investment in United States and foreign companies in the life sciences industry, including biotechnology, pharmaceutical, diagnostics, managed healthcare and medical equipment, hospitals, healthcare information technology and services, devices and supplies, and agriculture and environmental management. The Fund invests primarily in securities of public and private companies, which have the potential for above-average growth. The Fund invests up to 20% of its net assets in securities of foreign issuers, expected to be located primarily in Western Europe, Canada and Japan, and securities of United States issuers that are traded primarily in foreign markets. The Fund's investment adviser is abrdn Inc.

Industry: UNKNOWN Peers: